Form 4: Intuitive Surgical VP Fredrik Widman Executes Stock Option and Sells Shares Under 10b5-1 Plan

VP Corporate Controller Fredrik Widman of Intuitive Surgical executed stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• On March 15, 2024, Fredrik Widman, VP Corporate Controller of Intuitive Surgical Inc., engaged in multiple transactions involving the company's common stock.
• Widman exercised non-qualified stock options to acquire 1,224 shares at a price of $59.2278 per share.
• Simultaneously, Widman sold 5,041 shares of common stock at a price of $397.07 per share.
• These transactions were executed under a pre-arranged trading plan that complies with SEC Rule 10b5-1, set to expire on March 7, 2025.
• Following these transactions, Widman directly owns 722 shares of common stock and 612 derivative securities.

Sentiment

Score: 5

Explanation: The document reflects routine insider trading activity under a pre-arranged plan, indicating a neutral sentiment.

Future Outlook

The reporting person will continue to execute trades under the 10b5-1 trading plan until its expiration on March 7, 2025.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives, which is a standard practice in publicly traded companies.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a form of long-term incentive.
• The use of 10b5-1 trading plans is a common practice among corporate insiders to avoid accusations of insider trading.
• Companies like Medtronic and Stryker also have executives who utilize similar trading plans.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders as they are part of a pre-defined trading plan.
• Shareholders may view the transactions as a routine part of executive compensation.

Key Dates